Beta-Blockers May Not Improve Outcomes For Heart Attack Patients Without Cardiac Failure, Says Study
Beta-blockers target beta receptors in the body that are responsible for increasing blood pressure.
Stay updated with breaking news from Beta Blocker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beta-blockers target beta receptors in the body that are responsible for increasing blood pressure.
The accepted clinical practice of using beta blockers over the long term to curb the risk of further heart attacks or death doesn't seem to be warranted in patients who don't have heart failure, suggests a large study published in the journal Heart.
Data Bridge Market Research completed a qualitative study titled "Fatty Liver Diseases Treatment Market" with 100+ market data tables, pie charts, graphs, and
1. A significant reduction in all-cause mortality was seen among patients in the intervention group compared to usual care. 2. Over 36 months, the net group difference in systolic blood pressure was -23.1 mmHg while the difference in diastolic blood pressure was -9.9 mmHg, favouring the intervention group. Evidence Rating Level: 1 (Excellent) Study Rundown:
New research at Cleveland Clinic expands the link between what we eat and how the gut microbiome impacts our susceptibility to develop different diseases – in this case, how a specific gut microbe-generated byproduct is linked to heart failure risk.